Method of providing anxiolytic and antipsychotic treatment

Details Method of providing anxiolytic and antipsychotic treatment Method of providing anxiolytic and antipsychotic treatment

1991-10-31

1992-08-25

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

548315, 548194, 548234, 558 17, 560 35, 560 43, 564 26, A01N 4350, C07D26302, C07C33100

Patent

active

051419491

ABSTRACT:
Anxiolytic and antipsychotic treatment is provided to patients by administering therapeutically effective amounts of N-[2-(diethylamino)-ethyl]-2-methoxy-4-[(1-H-4,5-dihydro-2-imidazolyl)-ami no]-5-chlorobenzamide, or a pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 3342826 (1967-09-01), Miller
patent: 4210660 (1980-07-01), Takashima et al.
patent: 4835172 (1980-05-01), Acher et al.
patent: 4877780 (1989-10-01), Vega-Noverola et al.
Crawley, "Neuropharmacological Specificity", Pharmac. Biochem. & Behav. vol. 15, pp. 695-699 (1981).
Costall, "Actions of Supliride", Neuropharmacology, vol. 26, No. 2-3, pp. 195-200 (1987).
Cook et al. "Drug Effects on the Behavior of Animals", Annals of the New Academy of Sciences, vol. 96, pp. 315-335 (1962).
Costall et al. "Exploration of Mice", Pharmacology Biochem. & Behavior, vol. 32, pp. 777-785 (1989).
Harrington et al. "Metoclopramide" Drugs, vol. 25, pp. 451-494.

Affiliated with

Also associated with

Rating

Method of providing anxiolytic and antipsychotic treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of providing anxiolytic and antipsychotic treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of providing anxiolytic and antipsychotic treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-385270